ABSTRACT
Introduction
Surgery for refractory temporal lobe epilepsy (TLE) has been a well-defined procedure to provide seizure control in the recent years [1] [2] [3] [4] . When the epileptogenic zone (EZ) can be adequately localized through neuroimaging (mainly MRI), electroencephalographic (EEG) and neuropsychological testing, the benefits of surgery far exceed those of medication alone in this group, with a remission rate ranging from 61% to 94% [4] [5] [6] [7] . However, worse results were obtained in patients with normal MRI, discordant pre-operative clinical data and bilateral surface EEG temporal lobe spiking, especially in the pre-MRI era surgical treatment and seizure outcome for patients with MRI features of TLE with bilateral mesial temporal sclerosis (bMTS) 10, 12 . Evidence suggest a possible worse outcome of patients with bMTS when compared to those with TLE and unilateral mesial temporal sclerosis (uMTS), mainly because the presence of a wider and/or secondary EZ 13 .
The aim of the present study is to evaluate the seizure outcome of patients with TLE and bMTS after corticoamygdalohippocampectomy (CAH) compared to those with TLE and uMTS in order to verify the possible clinical and sociodemographic differences between these two groups associated with a possible worse seizure outcome.
Methods

Study Delineation
A case-controlled investigation was conducted with data collection of a patients' cohort from the epilepsy clinic of Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP), a Brazilian tertiary referral epilepsy center, from January 2000 to March 2012. Patients with neuroradiological evidence and neuropathological confirmation of other diseases than MTS, as well as additional potential epileptogenic MRI-lesions, were excluded.
Clinical data were obtained retrospectively from the patient record and files. For all patients with the diagnosis of MTS on MRI, the following data were collected: gender, age at surgery, handedness, type and number of AEDs used and results of neuropsychological assessment. In addition, non-invasive video-EEG data and side of surgery were registered.
Video-EEG Monitoring
All patients were submitted to non-invasive video-EEG monitoring using the Stella system, Neuro Workbench software and a Nihon Kohden hardware to record and evaluate the epileptic events. Every patient was analyzed by an experienced epileptologist as an integral part of inpatient assessment.
Neuropsychological Assessment
All patients were submitted to a neuropsychological assessment pre-and post-surgically (at 12 months). Verbal memory was assessed by a list of learning design, and figural memory by a design learning test using independent items. Memory deficits were defined as performance one standard deviation below of the normal performance of age-matched controls.
Magnetic Resonance Imaging
Brain MRI were obtained accordingly with a specific epilepsy protocol using a 1.5 Tesla Scanner, Philips. After displaying the sagittal 3D T1-weighted gradient-echo sequences, the next sequences were an axial and coronal fluid-attenuated inversion recovery (FLAIR) fast spin-echo (section thickness, 3 mm), axial and coronal T2-weighted fast spin-echo (section thickness, 2 mm) and T1-weighted inversion recovery sequences (section thickness, 5 mm).
All MRIs were analyzed by an experienced neuroradiologist who confirmed the visual radiological diagnosis of MTS. Previously, it was determined to be present if atrophy, an increased T2-weighted signal, a decreased T1-weighted signal and a disrupted internal structure of the hippocampus were present, accompanied by atrophy of the amygdala and/or temporal pole signal alteration on visual inspection of the MRI images. If only unilateral involvement of mesial temporal structures was observed, the patient was included in the uMTS group. On the other hand, if bilateral involvement was noted, patients were included in the bMTS.
Neuropathological Assessment
Biopsy specimens were obtained from all bMTS and uMTS patients who underwent surgical treatment, and a standardized neuropathological analysis was performed. Surgical specimens were microscopically analyzed using hematoxylin-eosin staining. MTS was diagnosed via pathological findings: cell loss in the CA3 and CA1 pyramidal cells and dentate gyrus neurons with relative sparing of the dentate granular cells and CA2 pyramidal cells. The pathologist reported their findings independently of clinical or imaging data. Patients with dual pathology (MTS plus another epileptogenic lesion) were excluded.
Surgical Technique
The surgical approach was similar for all patients, and only one neurosurgeon experienced in surgery for epilepsy (SCS Jr.) performed all patients' surgeries. Patient positioning included placing a shoulder roll to elevate the trunk and then turning the head 15-20 degrees from the midline so that the operative side is up. The head is slightly extended to bring the sylvian fissure to a perpendicular plane to the operating approach. Finally, dropping the vertex down toward the floor improves the surgeon access to mesial structures and allows less retraction on the temporal lobe. A reverse question mark incision was made from just above the
Results
Pre-surgical Demographic and Clinical Characteristics
During the period of the study, 533 patients underwent multidisciplinary investigation of epilepsy and 229 (42.9%) fulfilled the criteria to be included in the present study; 60 (26.2%) with bMTS and 169 (73.8%) with uMTS. In Table 1 , the descriptive data analysis is presented. Pathological investigation confirmed MTS in all patients enrolled in the study zigoma extending back in the temporal region. An anterior temporal craniotomy was performed respecting the anatomical landmarks of the temporal lobe from the root of the zygoma to the anatomic keyhole. The anterior and lateral remaining bone was removed by drilling down to the limits of the medial fossa floor. At the end of the craniotomy, all bone edges were waxed as necessary, any exposed air cells sealed and take-up sutures were performed before opening the dura-mater to prevent epidural bleeding. A maximum of 4.0 to 5.0 cm of the anterior lateral temporal lobe was resected. The mesial resection included amygdala removal and the anterior 2.0 to 3.0 cm of the hippocampus.
Follow-Up
Follow-up investigation were carried out 6 months and, if available 12 and 24 months after surgery. Patients with post-surgical followup periods less than 24 months were excluded from further analysis. At the 12-month follow-up, all patients received a neurological examination including observation of behavior disorders, investigation of seizure outcome, new EEG and a cerebral 1.5 Tesla MRI. Seizure outcome was classified as completely seizurefree since surgery (including auras), i.e. Engel Ia, or not seizurefree (Engel Ib-IV). Operative mortality was defined as death within 30 days of surgery.
Ethical Statement
The Ethical Committee of our institution analyzed the project of the present study and approved the performance of our investigations. The study complies with the Declaration of Helsinki. Informed consent was taken from all patients and/or genitors.
Statistical Analysis
The software used to perform statistical analysis were Microsoft Excel 2013, R 3.0.3 and SPSS. Data collected from all patients were organized in tables comparing to previous studies. Averages were expressed by means ±SD for parametric data and by median values for nonparametric data. A generalized linear model was performed in order to verify possible clinical and sociodemographic variables associated with a satisfactory seizure outcome (Engel I). The Chisquared Pearson and R2 coefficients according to the variables were used for correlation study, and the survival analysis theory was used to evaluate the patients' post-surgical outcome. A normal distribution to sample collected data was assumed. Seizure-free survival rate was assessed using Kaplan-Meier curves and MontelCox chi-square test. A p-value<0.05 was considered statistically significant.
Seizure outcome and Follow-Up
In Table 2 , seizure-outcome data are presented accordingly with a descriptive analysis of Engel Classification for patients with bMTS and uMTS following surgery. A regression analysis was performed in order to study the pre-surgical characteristics that would influence seizure outcome. In the uMTS group, the variables associated with an "Engel I" outcome were handedness, presence febrile seizures and unilateral ictal EEG. Table 4 summarizes the rate of patients Engel I after 24 months of follow-up of both uMTS and bMTS groups. We observed that 107 (63.3%) and 37 (61.6%) patients from uMTS and bMTS group, respectively, were Engel I at six months of follow-up. Among the uMTS group, 10 patients changed Engel classification during follow-up, while 5 patients changed Engel classification in bMTS group. Therefore, 90.7% of patients with uMTS and 86.5% of patients with bMTS maintained Engel I classification. It was also observed that unilateral or bilateral MTS did not interfere within the time interval of seizure freedom (p-value: 0.493). Table 5 describes the inference for mean survival and figure 1 shows the graphic curve of Kaplan-Meier seizure-free survival of patients with uMTS and bMTS. Table 2 . Seizure-outcome according to Engel Classification for patients with bMTS and uMTS following surgery. Table 3 . Main characteristics that influence postoperative outcome for seizurefreedom in patients with uMTS. Table 4 . Seizure-free (Engel I) survival descriptive analysis after 24 months of follow-up. The Table 3 resumes the main characteristics that influence postsurgical outcome for seizure-freedom (Engel I). Right-handed patients presented a probability of Engel I outcome of 1.33, more than twice of left-handed patients. Patients without history of febrile seizure presented a probability of Engel I outcome of 1.20, more than twice of those with history of febrile seizure. Patients with unilateral ictal EEG presented a probability of Engel I of 1.23, more than twice comparing to those with bilateral ictal EEG. In the bMTS group, the variable most associated with Engel I outcome was ictal EEG. Patients with unilateral ictal EEG presented a probability of Engel I outcome of 1.87, more than twice comparing to those with bilateral ictal EEG ( Table 3 ). 
Discussion
The first surgical intervention for the treatment of epilepsy was performed by Horsley, in 1886, and involved a cortical resection in a patient suffering from posttraumatic epilepsy 14 . Penfield and Flanigin 15 reported the first series of surgery for refractory TLE, and since then, the potential impact of surgery to reduce seizure tendency has been well documented, with some centers reaching 80% to 90% of favorable seizure outcome [16] [17] [18] [19] . Brain imaging, EEG, neuropsychology and seizure semiology are the most important components of the evaluation to localize the EZ 20 . These investigations allow for the appropriate selection of patients that will benefit from surgery and prognosticate the surgical result. Patients with radiological or electrographic evidence of multiple seizure foci are generally considered bad candidates for resective surgery or not candidates at all due to the perceived inability to achieve good results on seizure tendency [21] [22] [23] .
Recent reports have shown more favorable results from surgery for bilateral TLE, especially those with radiological evidence of involvement of both mesial temporal regions [10] [11] [12] . Boling et al. 11 reported 50% to 60% seizure free depending on the ictal onset focus of epileptogenic pattern on EEG, either bilateral or predominantly unilateral, respectively. Malter et al. 12 , comparing surgical outcome of patients with uMTS and bMTS, observed no difference in seizure-free outcomes at 12 and 24 months, although a great decrement of seizure-free patients in the bMTS group was observed on the study (82% to 57%). Seizure outcome in our operated patients with MRI features of bMTS was satisfactory and not inferior to that of uMTS patients in terms of seizure-freedom. It was also noted that both groups presented similar seizure-free survival curves, with 90.7% and 86.5% of Engel I patients at 6 months after surgery from groups uMTS and bMTS, respectively, still being seizure-free at 24 months of follow-up. The results are similar to other series investigating the evolution of seizure-free survival of patients with MTS 4, 17, 19, 24 . So et al. 9 investigating patients with intracranial electrode monitoring reported that 60% of patients with unilateral seizure predominance had none or rare seizures after surgery, whereas none was seizure free with less than 80% seizure laterality. Boling et al. 11 analyzing well lateralized seizure onset (>80% of seizures recorded from one temporal lobe) and poorly lateralized patients (<80% of seizures recorded from a single side), identified seizure freedom in 60% and 50%, respectively. The present study reinforces the importance of lateralization on ictal EEG. In patients from the group bMTS, when the ictal EEG lateralizes predominantly to a single lobe, i.e. assumes the value "unilateral", the probability that the patient will evolve to seizure freedom (Engel I) is 1.87, more than twice of patients with bilateral ictal onset (p<0.001). In the group uMTS, the main variables were handedness, febrile seizure and ictal EEG, however only the first assumed statistical significance. These results highlight the importance of a careful investigation of patients with bMTS when considering surgical treatment.
There are several methodological aspects in the present findings, which should be interpreted in the context of a number of limitations. First, this study is a non-randomized retrospective investigation performed in a highly selected population of a tertiary epilepsy center. Second, these findings cannot be generalized for all types of TLE since patients with dual pathology or single disease other than MTS were excluded. Furthermore, cognitive and memory outcomes were not reported in the present study. On the other hand, the strengths of the present study include the relatively large number of patients and extended follow-up duration. Notwithstanding some limitations, the present study was able to demonstrate that surgery may produce favorable results and provide remarkable seizure alleviation in patients with TLE and bilateral or unilateral MTS.
Conclusion
To conclude, the present investigation reinforces that favorable seizure outcome can be obtained in patients with TLE and bMTS after adequate pre-surgical workup. The side of the surgery in patients with bMTS should be determined after weighting multiple factors, most importantly, lateralization of the ictal zone, the most significant side of hippocampal atrophy on MRI and the side of seizure onset most debilitating for the patient.
